Effects of dehydration on corneal tissue absorption of topical azithromycin in rabbits

Current Eye Research

Volumn 30, Issue 10, 2005, Pages 915-918

  Tabbara, Khalid F ^a,b,c   Kotb, Amgad A ^c   Hammouda, Ehab F ^c   ElKum, Naser ^a  

^a KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTER   (Saudi Arabia)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c The Eye Foundation for Research in Ophthalmology   (Saudi Arabia)

Author keywords

Antibiotics; Azithromycin; Cornea; Dry eyes; Keratitis

Indexed keywords

AZITHROMYCIN;

ANIMAL EXPERIMENT; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CORNEA EPITHELIUM; DEHYDRATION; DESICCATION; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG INSTILLATION; DRY EYE; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MALE; MASS SPECTROMETER; MEDICAL ASSESSMENT; NONHUMAN; PRIORITY JOURNAL; RABBIT; STATISTICAL SIGNIFICANCE; STUDENT T TEST; TISSUE SECTION;

ABSORPTION; ADMINISTRATION, TOPICAL; ANIMALS; ANTI-BACTERIAL AGENTS; AZITHROMYCIN; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CORNEA; DESICCATION; FEMALE; MALE; RABBITS; TIME FACTORS;

EID: 31544479083     PISSN: 02713683     EISSN: None     Source Type: Journal    
DOI: 10.1080/02713680500306223     Document Type: Article

References (14)

1. Bailey RL, Arrulendran P, Whittle HC, Mabey DC. Randomized controlled trial of a single-dose Azithromycin in treatment of trachoma. Lancet. 1993;342:453-456.
2. Tabbara KF, Abu El-Asrar A, Al-Omar O, Choudhury AH, Al-Faisal Z. Single-dose azithromycin in the treatment of trachoma. A randomized, controlled study. Ophthalmology. 1996;103:842-846.
3. Dawson CR, Schachter J, Sallam S, Sheta A, Rubenstein RA, Washton H. A comparison of oral azithromycin with topical oxytetracycline/polymyxin for the treatment of trachoma in children. Clin Infect Dis. 1997;24:363-368.
4. Bowman RJ, Sillah D, Dehn C, Goode VM, Muquit M, Johnson GJ, Milligan P, Rowley J, Faal H, Bailey RL. Operational comparison of single-dose azithromycin and topical tetracycline for trachoma. Invest Ophthalmol Vis Sci. 2000;41:4074-4079.
5. Mabey DC, Solomon AW, Foster A. Trachoma. Lancet. 2003;362:223-229.
6. Foulds G, Shephard RM, Johnson RB. The pharmacokinetics of azithromycin in human serum and tissues. J Antimicrob Chemother. 1990;25(Suppl A):73-82.
7. Lode H, Borner K, Koeppe P, Schaberg T. Azithromycin - review of key chemical, pharmacokinetic and microbiological features. J Antimicrob Chemother. 1996;37(Suppl C):1-8.
8. Tabbara KF, Al-Kharashi SA, Al-Mansouri SM, Al-Omar OM, Cooper H, Abu El-Asrar AM, Foulds G. Ocular levels of azithromycin. Arch Ophthalmol. 1998;116:1625-1628.
9. Rodvold KA, Danziger LH, Goffried MH. Steady-state plasma and bronchopulmonary concentrations of intravenous levofloxacin and azithromycin in healthy adults. Antimicrob Agents Chemother. 2003;47:2450-2457.
10. Kuehne JJ, Yu AL, Holland GN, et al. Corneal pharmacokinetics of topically applied azithromycin and clarithromycin. Am J Ophthalmol. 2004;138(4):547-553.
11. Shephard RM, Duthu GS, Ferraina RA, Mullins MA. High-performance liquid chromatographic assay with electrochemical detection for azithromycin in serum and tissues. J Chromatogr. 1991;565:321-337.
12. Riedel KD, Wildfeur A, Laufen H, Zimmermann T. Equivalence of a high-performance liquid chromatographic assay and a bioassay of azithromycin in human serum samples. J Chromatogr. 1992;376:358-362.
13. Hosseini K, Kholodnykh AI, Petrova IY, Esenaliev RO, Hendrikse F, Motamedi M. Monitoring of rabbit cornea response to dehydration stress by optical coherence tomography. Invest Ophthalmol Vis Sci. 2004;45(8):2555-2562.
14. De Paiva CS, Harris LD, Pflugfelder SC. Keratoconus-like topographic changes in keratoconjunctivitis sicca. Cornea. 2003;22(1):22-24.